Bacteria continue to develop resistance against antibiotics, including last-resort ones, reinforcing the urgent need for new antimicrobial strategies. Chemicals at infection sites in the host often influence microbial virulence and antibiotic response; such interactions may offer new antimicrobial targets. Polyamines are cationic small molecules bacteria may encounter at infection sites. They are overproduced during infection, modulating host immune responses. The ability of bacteria to detoxify polyamines such as by a spermine/spermidine acetyltransferase (SpeG) correlated with hypervirulence of pathogens, including Salmonella Typhimurium, Enterococcus faecium, and the community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strain USA300. Polyamines may also influence bacterial antibiotic response. For example, we found that USA300 uses exogenous polyamines to resist antibiotics, including vancomycin, a phenotype lost in the ΔspeG mutant. Therefore, we aimed to uncover inhibitors of polyamine detoxification. A high-throughput chemical screen against S. aureus USA300 identified OES2-0017, which showed potent synergy with polyamines and growth-inhibitory effects at the low micromolar range. We revealed a dual mode of action of OES2-0017, where low concentrations inhibited SpeG and other polyamine detoxification enzymes, and higher concentrations perturbed the bacterial membrane. Eukaryotic cell membranes were not impacted at the same concentration range, as observed in a hemolysis assay. OES2-0017 abolished the polyamine-mediated antibiotic resistance in MRSA USA300, suggesting its potential utility as an antibiotic adjuvant. Notably, OES2-0017 showed similar polyamine synergy and growth inhibitory activities against other Gram-positive (e.g., E. faecium and E. faecalis) and Gram-negative (e.g., Klebsiella pneumoniae, S. Typhimurium, and Burkholderia cenocepacia) pathogens. OES2-0017 prevented S. Typhimurium from replicating in murine macrophages, which also suggests its potential application as an antivirulence agent. Together, this work exploits understudied aspects of chemically mediated host-pathogen interactions, offering a potential new antimicrobial strategy with a novel mode of action for multidrug-resistant priority pathogens.